Evidence map›Paper›PMID 39330484›Full record

ReviewMetabolites2024

The Association between Maternal Endocrine-Disrupting Chemical Exposure during Pregnancy and the Incidence of Male Urogenital Defects: A Systematic Review and Meta-Analysis.

Emad Ali Albadawi, Naweed SyedKhaleel Alzaman, Yasir Hassan Elhassan, Heba M Eltahir, Mekky M Abouzied, Muayad Saud Albadrani

Abstract readReview
In one paragraph

Review in Metabolites, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emad Ali AlbadawiDepartment of Basic Medical Sciences, College of Medicine, Taibah University, Al-Madinah Al-Munawara 42354, Saudi Arabia.
Naweed SyedKhaleel AlzamanDepartment of Medicine, College of Medicine, Taibah University, Al-Madinah Al-Munawara 42354, Saudi Arabia.ORCID 0000-0002-1543-1132
Yasir Hassan ElhassanDepartment of Basic Medical Sciences, College of Medicine, Taibah University, Al-Madinah Al-Munawara 42354, Saudi Arabia.ORCID 0000-0003-0196-5413
Heba M EltahirDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Al-Munawara 42354, Saudi Arabia.
Mekky M AbouziedDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Al-Munawara 42354, Saudi Arabia.
Muayad Saud AlbadraniDepartment of Family and Community Medicine and Medical Education, College of Medicine, Taibah University, Al-Madinah Al-Munawara 42354, Saudi Arabia.ORCID 0000-0002-7486-1677

Funding

The Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia 442/223
6 · The paper itself

Abstract

The increasing incidence of hypospadias and cryptorchidism, coupled with the widespread presence of endocrine-disrupting chemicals (EDCs), has raised concerns about the potential impact of these environmental factors on male urogenital development. This systematic review and meta-analysis aims to evaluate the association between maternal exposure to various EDCs and the risk of hypospadias and cryptorchidism. We conducted a comprehensive search of PubMed, Scopus, Web of Science, and Cochrane databases from inception until May 2024. We included case-control and cohort studies that examined the association between maternal EDC exposure and hypospadias or cryptorchidism, reporting adjusted odds ratios (aOR) or crude odds ratios (cOR). Data were extracted and pooled using a random effects model, and heterogeneity was assessed using the Q test and I-square statistics. The risk of bias was evaluated using the Newcastle-Ottawa Scale (NOS). A total of 48 studies were included in the systematic review, with 46 studies included in the meta-analysis. The pooled analysis revealed a significant association between maternal EDC exposure and an increased risk of hypospadias (aOR = 1.26, 95% CI: 1.18-1.35,

Indexed as

cryptorchidismEDCendocrine-disrupting chemicalshypospadiasurogenital defects

Identifiers

PMID39330484
PMCPMC11434617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.